Bunkerhill ECG-EF vs CAC Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by 4DMedical (Imbio CAC Software)

AI Verdict

Tool A focuses on detecting reduced left ventricular ejection fraction from ECGs to identify heart failure risk. Tool B, conversely, analyzes non-contrast chest CTs to quantify coronary artery calcification for coronary artery disease risk assessment. While both are non-invasive cardiology AI tools, they utilize different imaging modalities and target distinct cardiac conditions, making them complementary rather than directly interchangeable.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary goal is to rapidly screen a broad patient population for early signs of heart failure risk using existing, routine 12-lead ECG data. This tool is ideal for identifying patients with reduced left ventricular ejection fraction (LVEF ≤ 40%) in a non-invasive and accessible manner, integrating seamlessly into automated clinical workflows to support timely intervention.

View Bunkerhill ECG-EF →

Choose CAC Software if…

Choose Imbio CAC Software if you need to precisely quantify coronary artery calcification from non-contrast chest CT scans to assess a patient's risk for coronary artery disease. This tool provides detailed metrics like the Agatston score and 3D visualizations, making it suitable for comprehensive cardiovascular risk stratification and guiding treatment decisions based on structural arterial health.

View CAC Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF CAC Software
Pricing Contact sales for pricing details. Unknown
Deployment Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. Cloud-based (SaaS), integrates with PACS
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC Software

Tool B emphasizes fully automated processing with no user input or intervention, integrating directly into existing DICOM workflows without requiring new workstations or user interfaces. While Tool A offers seamless EHR integration and automated workflows via its 'no-code' Carebricks platform and conversational AI, Tool B's approach to completely hands-off operation for its core function offers a slightly more streamlined user experience for image analysis.

Clinical Value

Bunkerhill ECG-EF

Tool A detects reduced LVEF from routine ECGs, enabling early identification of heart failure risk from a widely accessible and inexpensive test, potentially impacting millions of undiagnosed patients at scale. Tool B provides detailed quantification of coronary artery calcification from CT scans, which is crucial for CAD risk assessment and can be integrated into screening programs. However, the broad accessibility of ECGs gives Tool A a slight edge in terms of population-level screening and early intervention for a prevalent condition like heart failure.

Pricing & Value

Tie

Both Tool A and Tool B explicitly state 'contact for pricing' in their available information. Without any public details on their pricing models, subscription costs, or typical implementation expenses, it is not possible to conduct a head-to-head comparison of their pricing or overall value.

Enterprise Readiness

CAC Software

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong enterprise readiness. However, Tool B explicitly offers a wider array of deployment options including Cloud, On-premise, and through various partner platforms (e.g., Nuance, Aidoc, Siemens Syngo.via). This comprehensive flexibility in deployment caters to diverse enterprise IT infrastructures and existing AI ecosystems more explicitly than Tool A's 'seamless integration with EHRs and clinical archives'.

Innovation

Bunkerhill ECG-EF

Tool A leverages 'Generative AI for clinical reasoning and action' through its Carebricks platform, which not only analyzes data but also helps determine appropriate steps and automate actions, including conversational AI for patient records. While Tool B uses deep learning for automated quantitative imaging and 3D visualization, Tool A's broader generative AI approach for reasoning and automated action represents a more advanced and comprehensive application of AI in clinical workflows.

Support & Docs

CAC Software

Tool B clearly outlines its support structure, offering 24/7/365 customer support via phone, email, and online case submission, and explicitly mentions the availability of user manuals and product documentation upon request. Tool A provides general contact information and mentions resources like case studies, but lacks specific details on the breadth and availability of its customer support or explicit documentation access.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF CAC Software
Tool Name Bunkerhill ECG-EF CAC Software
Company BunkerHill Health Imbio
Description FDA-cleared artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. Automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT).
Primary Function Detects reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from 12-lead ECGs. Quantifies coronary artery calcification from non-contrast chest CT scans.
Data Input Routine 12-lead electrocardiograms (ECGs) Non-contrast, chest computed tomography (CT) scans
Key Outputs/Metrics Early identification of patients at risk for heart failure (reduced LVEF) Agatston score, arterial age, calcified lesion mass and volume; 3D visualizations and annotated images

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and CAC Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF is an FDA-cleared AI algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure. Imbio CAC Software is designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries from non-contrast chest CT scans, supporting risk assessment for coronary artery disease.
Bunkerhill ECG-EF analyzes routine 12-lead electrocardiogram (ECG) data. Imbio CAC Software performs its analysis on non-contrast chest computed tomography (CT) scans.
Bunkerhill ECG-EF provides an AI algorithm-driven detection of reduced LVEF (u2264 40%). Imbio CAC Software outputs include the Agatston score, arterial age, calcified lesion mass and volume, along with 3D visualizations and annotated images.
Bunkerhill ECG-EF integrates seamlessly with Electronic Health Records (EHRs), Electronic Medical Records (EMRs), or ECG Management Systems (EMS). Imbio CAC Software integrates into existing DICOM viewing workflows.
AI Tool Finder
AI-powered search. Results may not be comprehensive.